T2 Biosystems’ stock extends losing streak despite FDA approval for anthrax and plague diagnostic test
September 20, 2023 at 16:50 PM EDT
Shares of T2 Biosystems extended their losing streak to two days Wednesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.